放射学实践
放射學實踐
방사학실천
RADIOLOGIC PRACTICE
2014年
12期
1396-1400
,共5页
熊炜烽%徐向东%江新青%邱士军%刘国顺%杨蕊梦%谌丹丹%周勇
熊煒烽%徐嚮東%江新青%邱士軍%劉國順%楊蕊夢%諶丹丹%週勇
웅위봉%서향동%강신청%구사군%류국순%양예몽%심단단%주용
鼻咽部肿瘤%脑疾病%辐射损伤%磁共振波谱学%磁共振成像
鼻嚥部腫瘤%腦疾病%輻射損傷%磁共振波譜學%磁共振成像
비인부종류%뇌질병%복사손상%자공진파보학%자공진성상
Nasopharyngeal neoplasm%Cerebral diseases%Radiation injury%Magnetic resonance spectroscopy%Magnetic resonance imaging
目的:探讨对鼻咽癌患者放疗后颞叶常规 MRI 上表现正常的脑白质采用1 H-MRS 进行监测的价值。方法:回顾性分析经活检病理证实的75例鼻咽癌患者的临床和影像资料,所有患者均行常规 MRI 和1 H-MRS 检查,且常规MRI 上无明显异常。以放疗前的18例患者作为对照组,放疗后的57例患者为放疗。根据进行 MRS 检查时处于放疗后的不同时期而将放疗组患者分为5个组:1组(放疗后≤3个月,16例)、2组(放疗后3~6个月,12例)、3组(放疗后6~9个月,10例)、4组(放疗后9~12个月,8例)、5组(放疗后>12个月,11例)。测量每例患者颞叶白质的平均 NAA/Cho、NAA/Cr 和 Cho/Cr,采用单因素方差分析对放疗前及放疗后各组的数据进行分析。结果:各组间 NAA/Cho 和 NAA/Cr的均值间的差异均有统计学意义(F 值分别为8.394、4.855,P 值均<0.05)。进一步两两比较,放疗后一年内(1~4组)各组中 NAA/Cho 和 NAA/Cr 的均值均较放疗前明显下降,差异有统计学意义(P <0.05);而放疗一年以上组(5组)的平均NAA/Cho 和 NAA/Cr 基本恢复,与放疗前的差异无统计学意义(P >0.05)。放疗后各组的平均 Cho/Cr 对比放疗前差异均无统计学意义(P >0.05)。结论:对鼻咽癌放疗后患者,1 H-MRS 可以在常规 MRI 发现异常之前检测到脑白质代谢异常,为临床早期诊断提供更多影像学证据。
目的:探討對鼻嚥癌患者放療後顳葉常規 MRI 上錶現正常的腦白質採用1 H-MRS 進行鑑測的價值。方法:迴顧性分析經活檢病理證實的75例鼻嚥癌患者的臨床和影像資料,所有患者均行常規 MRI 和1 H-MRS 檢查,且常規MRI 上無明顯異常。以放療前的18例患者作為對照組,放療後的57例患者為放療。根據進行 MRS 檢查時處于放療後的不同時期而將放療組患者分為5箇組:1組(放療後≤3箇月,16例)、2組(放療後3~6箇月,12例)、3組(放療後6~9箇月,10例)、4組(放療後9~12箇月,8例)、5組(放療後>12箇月,11例)。測量每例患者顳葉白質的平均 NAA/Cho、NAA/Cr 和 Cho/Cr,採用單因素方差分析對放療前及放療後各組的數據進行分析。結果:各組間 NAA/Cho 和 NAA/Cr的均值間的差異均有統計學意義(F 值分彆為8.394、4.855,P 值均<0.05)。進一步兩兩比較,放療後一年內(1~4組)各組中 NAA/Cho 和 NAA/Cr 的均值均較放療前明顯下降,差異有統計學意義(P <0.05);而放療一年以上組(5組)的平均NAA/Cho 和 NAA/Cr 基本恢複,與放療前的差異無統計學意義(P >0.05)。放療後各組的平均 Cho/Cr 對比放療前差異均無統計學意義(P >0.05)。結論:對鼻嚥癌放療後患者,1 H-MRS 可以在常規 MRI 髮現異常之前檢測到腦白質代謝異常,為臨床早期診斷提供更多影像學證據。
목적:탐토대비인암환자방료후섭협상규 MRI 상표현정상적뇌백질채용1 H-MRS 진행감측적개치。방법:회고성분석경활검병리증실적75례비인암환자적림상화영상자료,소유환자균행상규 MRI 화1 H-MRS 검사,차상규MRI 상무명현이상。이방료전적18례환자작위대조조,방료후적57례환자위방료。근거진행 MRS 검사시처우방료후적불동시기이장방료조환자분위5개조:1조(방료후≤3개월,16례)、2조(방료후3~6개월,12례)、3조(방료후6~9개월,10례)、4조(방료후9~12개월,8례)、5조(방료후>12개월,11례)。측량매례환자섭협백질적평균 NAA/Cho、NAA/Cr 화 Cho/Cr,채용단인소방차분석대방료전급방료후각조적수거진행분석。결과:각조간 NAA/Cho 화 NAA/Cr적균치간적차이균유통계학의의(F 치분별위8.394、4.855,P 치균<0.05)。진일보량량비교,방료후일년내(1~4조)각조중 NAA/Cho 화 NAA/Cr 적균치균교방료전명현하강,차이유통계학의의(P <0.05);이방료일년이상조(5조)적평균NAA/Cho 화 NAA/Cr 기본회복,여방료전적차이무통계학의의(P >0.05)。방료후각조적평균 Cho/Cr 대비방료전차이균무통계학의의(P >0.05)。결론:대비인암방료후환자,1 H-MRS 가이재상규 MRI 발현이상지전검측도뇌백질대사이상,위림상조기진단제공경다영상학증거。
Objectire:To explore the value of 1 H-MR spectroscopy in detecting radiation-induced changes of temporal lobe,which showed normal appearance in white matter (WM)on conventional MRI,in patients after radiation therapy (RT) for nasopharyngeal carcinoma (NPC).Methods:The clinical and imaging data (with no positive findings in white matter of temporal lobe on conventional MRI)of 75 patients with nasopharyngeal carcinoma proved pathologically by biopsy were ret-rospectively analyzed.All patients underwent conventional MRI and 1 H-MR spectroscopy examinations,including 18 cases before radiotherapy as the control group (pre-RT)and fifty-seven patients after radiotherapy as the post-RT group.The pa-tients in post-RT group were further divided into five groups based on the interval time between the MRS and completion of RT:group 1 (less than 3 months,16 cases),group 2 (3 to 6 months,12 cases),group 3 (6 to 9 months,10 cases),group 4 (9 to 12 months,8 cases),and group 5 (more than 12 months,11 cases).The mean NAA/Cho,NAA/Cr and Cho/Cr in bi-lateral temporal lobe were measured and calculated.The three indexes in pre-RT and five post-RT groups were compared by one-way ANOVA test.Results:The NAA/Cho and NAA/Cr in six groups were statistically different (F =8.394、4.855,re-spectively;P <0.05).By pairwise comparison,the mean NAA/Cho and NAA/Cr decreased significantly within 1 year after RT (group 1 to 4)when compared with pre-RT group,with statistic significance (P <0.05);however,there was no statistic difference between the group 5 and pre-RT group.The mean Cho/Cr in post-RT groups was not significantly different from that in the control group.Conclusion:1 H-MR specctroscopy can provide non-invasive and quantitative methods to detect the metabolic changes in white matter after RT,and may be an useful method for the early diagnosis of brain injury after radio-therapy.